IBRN P&L Curve
iShares Neuroscience and Healthcare ETF (IBRN) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $5.4M, listed on AMEX, carrying a beta of 0.87 to the broader market. The iShares Neuroscience and Healthcare ETF (IBRN) aims to mirror the financial performance of a particular index. public since 2022-08-24.
A profit/loss curve charts the theoretical gain or loss of an options position across a range of underlying prices. It helps traders visualize risk, identify breakeven points, and compare strategies before committing capital.
- Exchange
- AMEX
- Sector
- Financial Services
- Industry
- Asset Management
- Market Cap
- $5.4M
- IPO Date
- 2022-08-24
- Beta
- 0.87
As of Nov 13, 2026, the iShares Neuroscience and Healthcare ETF spot price is $34.18; P&L scenarios can be constructed from the options chain. Payoff diagrams should be rebuilt from the live options chain; the preceding values are illustrative and assume a single at-the-money straddle for reference.